公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 REVVITY DO BRASIL LTDA取消

92 记录

产品持有公司班级有效性
GSP Neonatal Phenylalanine Kit10298910119REVVITY DO BRASIL LTDAIII17/12/2027
GSP Neonatal Thyroxine (T4)10298910102REVVITY DO BRASIL LTDAIII17/05/2035
GSP TEST KIT10298910116REVVITY DO BRASIL LTDAI现有
GSP Wash Concentrate10298910113REVVITY DO BRASIL LTDAI现有
GSP® Neonatal Anti-Toxoplasma IgM Kit10298910178REVVITY DO BRASIL LTDAIV26/12/2033
GSP® Neonatal Galactose Total kit - PN 3309-002010298910171REVVITY DO BRASIL LTDAIII04/07/2032
KIT DELFIA AUTODELFIA 17 ALFA-HIDROXIPROGESTERONA NEONATAL10298910015REVVITY DO BRASIL LTDAIII23/09/2036
Kit Eonis SCID-SMA PN: 3241-002010298910182REVVITY DO BRASIL LTDAIII20/05/2034
Kit chemagic Pathogen NA gDNA10298910185REVVITY DO BRASIL LTDAI现有
Kit chemagic Viral DNA/RNA 300 K H96 PN IVD-1033-S10298910186REVVITY DO BRASIL LTDAI现有
Lifecycle 7.0 PN 5015 700010298919007REVVITY DO BRASIL LTDAII现有
MSMS Workstation PN 5002-054010298919008REVVITY DO BRASIL LTDAII现有
Migele Gel Electrophoresis Unit10298910142REVVITY DO BRASIL LTDAII现有
NEO NATAL BIOTINIDASE KIT10298910092REVVITY DO BRASIL LTDAIII14/07/2033
NEONATAL GALT KIT10298910099REVVITY DO BRASIL LTDAIII16/07/2034
NEONATAL PHENYLALANINE KIT10298910054REVVITY DO BRASIL LTDAIII21/07/2034
NEONATAL TOTAL GALACTOSE KIT10298910089REVVITY DO BRASIL LTDAIII14/04/2028
NeoBase 2 Non-derivatized Assay Solutions10298910146REVVITY DO BRASIL LTDAI现有
NeoBase 2 Non-derivatized MSMS kit 3044-001010298910147REVVITY DO BRASIL LTDAIII27/07/2030
NeoBase 2 Succinylacetone Assay Solution Kit10298910145REVVITY DO BRASIL LTDAI现有
NeoBase Non-Derivatized MSMS Kit10298910097REVVITY DO BRASIL LTDAIII13/04/2034
NeoBase Non-derivatized Assay Solutions10298910096REVVITY DO BRASIL LTDAI现有
NeoBase Succinylacetone Assay Solution10298910098REVVITY DO BRASIL LTDAI现有
NeoLSD MSMS Kit10298910139REVVITY DO BRASIL LTDAIII02/01/2028
PANTHERA - PUNCHER 910298919002REVVITY DO BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家